RFC2 Human shRNA Plasmid Kit (Locus ID 5982)
CAT#: TG309864
RFC2 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 3 publications. |
Product images
经常一起买 (2)
RFC2 mouse monoclonal antibody, clone OTI3A7 (formerly 3A7)
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Product Name | RFC2 Human shRNA Plasmid Kit (Locus ID 5982) |
Locus ID | 5982 |
UniProt ID | P35250 |
Synonyms | RFC40 |
Vector | pGFP-V-RS |
Format | Retroviral plasmids |
Kit Components | RFC2 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector(Gene ID = 5982). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-V-RS Vector, TR30013, included for free. |
RefSeq | NM_001278791, NM_001278792, NM_001278793, NM_002914, NM_181471, NM_002914.1, NM_002914.2, NM_002914.3, NM_002914.4, NM_181471.1, NM_181471.2, NM_001278793.1, NM_001278792.1, NM_001278791.1, BC002813, BC002813.1, BM563468, BM810551, NM_181471.3 |
Summary | This gene encodes a member of the activator 1 small subunits family. The elongation of primed DNA templates by DNA polymerase delta and epsilon requires the action of the accessory proteins, proliferating cell nuclear antigen (PCNA) and replication factor C (RFC). Replication factor C, also called activator 1, is a protein complex consisting of five distinct subunits. This gene encodes the 40 kD subunit, which has been shown to be responsible for binding ATP and may help promote cell survival. Disruption of this gene is associated with Williams syndrome. Alternatively spliced transcript variants encoding distinct isoforms have been described. A pseudogene of this gene has been defined on chromosome 2. [provided by RefSeq, Jul 2013] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (3)
The use of this RNAi has been cited in the following citations: |
---|
DNA damage response defect in Williams-Beuren syndrome
,Guenat, D;Merla, G;Deconinck, E;Borg, C;Rohrlich, PS;,
Int. J. Mol. Med.
,PubMed ID 28098859
[RFC2]
|
PLA2G16 represents a switch between entry and clearance of Picornaviridae
,Staring, J;von Castelmur, E;Blomen, VA;van den Hengel, LG;Brockmann, M;Baggen, J;Thibaut, HJ;Nieuwenhuis, J;Janssen, H;van Kuppeveld, FJ;Perrakis, A;Carette, JE;Brummelkamp, TR;,
Nature
,PubMed ID 28077878
[RFC2]
|
DNA damage response defect in Williams‑Beuren syndrome
,GUENAT, D;MERLA, G;DECONINCK, E;BORG, C;ROHRLICH, P;,
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
,PubMed ID 28350066
[RFC2]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...